arrow
P

Paradi Mirmirani

The Permanente Medical Group
H指数:33
被引数:3,206

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024

来自前额纤维性脱发国际专家联盟的声明:SOFFIA 2024

2025-07-230
OAAI
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme

在ALLEGRO临床开发计划中,接受利特昔替尼治疗斑秃患者的临床反应模式

2025-02-171
OAAI
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
2025-02-010
OAAI
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States
2023-04-015
OAAI
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata

选择性Janus激酶抑制剂CTP-543治疗中度至重度斑秃的2期随机,剂量范围试验

2022-08-0150
OA
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort
2022-02-0133
OA
Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)
2021-08-1323
OAAI
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata

斑秃专家共识 (ACE) 研究第二部分: 斑秃诊断和实验室评估的国际专家意见结果

2021-06-0144
PREAI
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
2021-04-0120
PRE
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
2020-07-01117
PREAI